NCT05040256View on ClinicalTrials.gov

Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

September 30, 2021

Conditions
CTLA4 Haploinsufficiency
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT05040256 - Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency | Biotech Hunter | Biotech Hunter